| Takeda Pharma AG - Agopton 15 mg, magensaftresistente Hartkapseln | | 51969 | | 02 | | Agopton 15 mg | | magensaftresistente Hartkapseln | | A02BC03 | | Lansoprazol | | 11.09.1995 | | |
| | Composition | | lansoprazolum 15 mg, magnesii subcarbonas ponderosus, sacchari sphaerae, saccharum, maydis amylum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas, macrogolum 8000, E 171, polysorbatum 80, talcum, silica colloidalis anhydrica, Kapselhülle: gelatina, aqua, E 171, pro capsula corresp. natrium max. 0.02 mg et saccharum max. 80.3 mg. | | Packungsbestandteile | | magensaftresistente Hartkapseln | | | | | | | | Principe actif | Concentr. |
|---|
| Lansoprazole | 15 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lansoprazole | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | | | Aqua | | | | E 171 | | color. | | Ethylis Acrylatis Polymerisatum Dispersio 30 per Centum cum Natrii Laurilsulfas | | | | Gelatina | | Kapselhülle | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Macrogol | 8000 | | | Magnesii Subcarbonas Ponderosus | | | | Maydis Amylum | | | | Polysorbatum 80 | | | | Sacchari Sphaerae | | | | Saccharum | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
